Cellnex Telecom SA (CLNX)
Madrid Exchange · Spain · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 26.20 |
|---|---|
| 52-week range | 21.84 – 32.71 |
| Return, 1 month / 3 months | +4.8% / +0.8% |
| Return, 1 year / 3 years | −8.2% / +1.8% |
| Trend | Below its 200-day average |
| RSI (14) | 66 |
| Volatility (1 year) | 28.4% |
| Worst drawdown (1 year) | -30.6% |
| Average daily value traded | 33.77M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cellnex Telecom is a Spanish company that owns and operates telecommunications infrastructure, chiefly wireless towers and rooftop sites that it leases to mobile network operators and other wireless carriers. It also provides related services such as site sharing and small-cell and distributed antenna systems for dense urban coverage. The company is based in Spain and works with telecom operators across several European countries, helping them host their antennas and network equipment.
On this site Cellnex Telecom SA appears as a stock on the Madrid Exchange (Spain), code CLNX, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cellnex Telecom SA (CLNX) trades on the Madrid Exchange in Spain. It last closed at EUR 26.20 on 23 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 129 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.2% and over the last three months it rose 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.6% | ||
| From 52-week high | -19.2% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.8% | ||
| 6-month return | -7.3% | ||
| 12-month return, skipping the last month | -12.4% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.6% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 33.77M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +4.8% |
| 3 months | +0.8% |
| 6 months | −7.3% |
| 1 year | −8.2% |
| 3 years | +1.8% |
| 5 years | −50.3% |
Signals
| 50-day / 200-day average | 25.08 / 26.91 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2026 | EUR 0.3769 |
| 13 Jan 2026 | EUR 0.3710 |
| 16 Jun 2025 | EUR 0.0167 |
| 19 Nov 2024 | EUR 0.0460 |
| 13 Jun 2024 | EUR 0.0168 |
| 21 Nov 2023 | EUR 0.0404 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.